Sandbox 09232014: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi- (talk | contribs) No edit summary |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 8: | Line 8: | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Exanthems | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Exanthems | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Delayed-type hypersensitivity <BR> Evolve over days after drug initiation <BR> Diffuse macules and papules | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Delayed-type hypersensitivity <BR> Evolve over days after drug initiation <BR> Diffuse macules and papules | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Allopurinol]], [[amphotericin]], [[barbiturates]], [[captopril]], [[carbamazepine]], [[cephalosporins]], [[chloramphenicol]], [[erythromycin]], [[furosemide]], [[gentamicin]], [[gold salts]], [[lithium]], [[nalidixic acid]], [[nitrofurantoin]], [[penicillins]], [[phenothiazines]], [[phenylbutazone]], [[phenytoin]], [[sulfonamides]]), [[thiazides]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Urticaria/ angioedema | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Urticaria/ angioedema | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Often IgE mediated <BR> Onset within minutes of drug initiation | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Often IgE mediated <BR> Onset within minutes of drug initiation | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ACE inhibitors]], [[aminosalicylic acid]], [[anticonvulsants]], [[aspirin]], [[atropine]], [[cephalosporins]], [[dextran]], [[hydralazine]], [[monoclonal antibodies]], [[NSAIDs]], [[opioids]], [[penicillins]], [[pentamidine]], [[quinine]], [[sulfonamides]], [[tetracyclines]], [[thiouracil]], [[tubocurarine]], [[vancomycin]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Fixed drug eruption | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Fixed drug eruption | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hyperpigmented plaques that recur at same skin or mucosal site | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hyperpigmented plaques that recur at same skin or mucosal site | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[NSAIDs]], [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ACE inhibitors]], [[allopurinol]], [[amlodipine]], [[aspirin]], [[barbiturates]], [[benzodiazepines]], [[carbamazepine]], [[cephalosporins]], [[clindamycin]], [[co-trimoxazole]], [[dextromethorphan]], [[diltiazem]], [[fluconazole]], [[lamotrigine]], [[lansoprazole]], [[metronidazole]], [[NSAIDs]], [[paclitaxel]], [[paracetamol]], [[penicillin]], [[phenolphthalein]][[omeprazole]], [[quinine]], [[salicylates]], [[sulfonamides]], [[terbinafine]], [[tetracyclines]], [[trimethoprim]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Pustules | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Pustules | ||
Line 26: | Line 26: | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Flaccid blisters: [[captopril]], [[penicillamine]] <BR> Tense blisters: [[furosemide]], [[vancomycin]] | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Flaccid blisters: [[captopril]], [[penicillamine]] <BR> Tense blisters: [[furosemide]], [[vancomycin]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Cutaneous lupus erythematosus | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Cutaneous lupus erythematosus | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Erythematous/scaly plaques in photodistribution | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Erythematous/scaly plaques in photodistribution | ||
Line 33: | Line 32: | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Stevens-Johnson syndrome (SJS) | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Stevens-Johnson syndrome (SJS) | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Purpuric macules on face and trunk with <10% epidermal detachment, fever, stomatitis, ocular involvement | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Purpuric macules on face and trunk with <10% epidermal detachment, fever, stomatitis, ocular involvement | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[antibiotics]], [[barbiturates]], [[Beta-lactam|β-lactam antibiotics]], [[carbamazepine]], [[chlorpropamide]], [[co-trimoxazole]], [[gold]], [[H2 blocker]], [[histamine]], [[lamotrigine]], [[leflunomide]], [[macrolides]], [[mefloquine]], [[NSAIDs]], [[phenothiazines]], [[phenytoin]], [[rifampicin]], [[sulfonamides]], [[tetracyclines]], [[thiazides]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Toxic epidermal necrolysis (TEN) | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Toxic epidermal necrolysis (TEN) | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Similar to SJS but >30% epidermal detachment | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Similar to SJS but >30% epidermal detachment | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Allopurinol]], [[barbiturates]], [[carbamazepine]], [[gold]], [[griseofulvin]], [[lamotrigine]], [[leflunomide]], [[nitrofurantoin]], [[NSAIDs]], [[penicillins]], [[phenytoin]], [[salicylates]], [[sulfonamides]], [[tetracyclines]] | ||
|} | |} | ||
Line 46: | Line 45: | ||
! style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Implicated medications}} | ! style="background: #4479BA; padding: 5px 5px;" | {{fontcolor|#FFFFFF|Implicated medications}} | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Pulmonary | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Pulmonary fibrosis, hypersensitivity pneumonitis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Nitrofurantoin]], [[bleomycin]], [[methotrexate]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Hepatic | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Hepatic | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hepatitis, | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hepatitis, cholestasis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Aminosalicylic acid|Para-aminosalicylic acid]], [[sulfonamides]], [[phenothiazines]] | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Aminosalicylic acid|Para-aminosalicylic acid]], [[sulfonamides]], [[phenothiazines]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Renal | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Renal | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Interstitial nephritis, membranous glomerulonephritis | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Interstitial nephritis, membranous glomerulonephritis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Penicillin]], [[sulfonamides]], [[gold]], [[penicillamine]], [[allopurinol]] | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Penicillin]], [[sulfonamides]], [[gold]], [[penicillamine]], [[allopurinol]] | ||
|- | |||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Hematologic | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Hemolytic anemia, thrombocytopenia, granulocytopenia | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Penicillin]], [[quinine]], [[sulfonamides]] | |||
|} | |} | ||
Line 70: | Line 69: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Anaphylaxis | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Anaphylaxis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Urticaria, angioedema, bronchospasm, gastrointestinal symptoms, hypotension | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Urticaria, angioedema, bronchospasm, gastrointestinal symptoms, hypotension | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Beta-lactam|β-lactam antibiotics]], [[monoclonal antibodies]] | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Beta-lactam|β-lactam antibiotics]], [[monoclonal antibodies]] | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Systemic lupus erythematosus | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Systemic lupus erythematosus | ||
Line 87: | Line 78: | ||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Vasculitis | | style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Vasculitis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Cutaneous or visceral vasculitis | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | Cutaneous or visceral vasculitis | ||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[ | | style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Allopurinol]], [[aspirin]], [[Beta-lactam|β-lactam antibiotics]], [[carbamazepine]], [[carbimazole]], [[co-trimoxazole]], [[diltiazem]], [[erythromycin]], [[furosemide]], [[gold]], [[G-CSF]], [[GM-CSF]], [[hydralazine]], [[interferons]], [[methotrexate]], [[minocycline]], [[NSAIDs]], [[penicillamine]], [[propylthiouracil]], [[retinoids]], [[sulfasalazine]], [[sulfonamides]], [[thiazides]], [[thrombolytics]] | ||
|- | |||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Serum sickness | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Urticaria, arthralgia, fever | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Heterologous]] [[antibodies]], [[infliximab]] | |||
|- | |||
| style="background: #DCDCDC; padding: 5px 5px; font-weight: bold;" valign=top | Drug reaction with eosinophilia and systemic symptoms (DRESS) | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | Cutaneous eruption, fever, eosinophilia, hepatic dysfunction, lymphadenopathy | |||
| style="background: #F5F5F5; padding: 5px 5px;" valign=top | [[Anticonvulsant]]s, [[sulfonamide]]s, [[minocycline]], [[allopurinol]] | |||
|} | |} | ||
<ref>{{Cite journal | doi = 10.1016/j.jaci.2009.10.028 | issn = 1097-6825 | volume = 125 | issue = 2 Suppl 2 | pages = –126-137 | last = Khan | first = David A. | coauthors = Roland Solensky | title = Drug allergy | journal = The Journal of Allergy and Clinical Immunology | date = 2010-02 | pmid = 20176256 }}</ref> | <ref>{{Cite journal | doi = 10.1016/j.jaci.2009.10.028 | issn = 1097-6825 | volume = 125 | issue = 2 Suppl 2 | pages = –126-137 | last = Khan | first = David A. | coauthors = Roland Solensky | title = Drug allergy | journal = The Journal of Allergy and Clinical Immunology | date = 2010-02 | pmid = 20176256 }}</ref><ref>{{cite book | last = Lee | first = Anne | title = Adverse drug reactions | publisher = Pharmaceutical Press | location = London Chicago | year = 2006 | isbn = 0853696012 }}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Latest revision as of 20:34, 23 September 2014
Organ-specific reactions | Clnical features | Implicated medications |
---|---|---|
Pulmonary | Pulmonary fibrosis, hypersensitivity pneumonitis | Nitrofurantoin, bleomycin, methotrexate |
Hepatic | Hepatitis, cholestasis | Para-aminosalicylic acid, sulfonamides, phenothiazines |
Renal | Interstitial nephritis, membranous glomerulonephritis | Penicillin, sulfonamides, gold, penicillamine, allopurinol |
Hematologic | Hemolytic anemia, thrombocytopenia, granulocytopenia | Penicillin, quinine, sulfonamides |
Multiorgan reactions | Clnical features | Implicated medications |
---|---|---|
Anaphylaxis | Urticaria, angioedema, bronchospasm, gastrointestinal symptoms, hypotension | β-lactam antibiotics, monoclonal antibodies |
Systemic lupus erythematosus | Arthralgia, myalgias, fever, malaise | Hydralazine, procainamide, isoniazid |
Vasculitis | Cutaneous or visceral vasculitis | Allopurinol, aspirin, β-lactam antibiotics, carbamazepine, carbimazole, co-trimoxazole, diltiazem, erythromycin, furosemide, gold, G-CSF, GM-CSF, hydralazine, interferons, methotrexate, minocycline, NSAIDs, penicillamine, propylthiouracil, retinoids, sulfasalazine, sulfonamides, thiazides, thrombolytics |
Serum sickness | Urticaria, arthralgia, fever | Heterologous antibodies, infliximab |
Drug reaction with eosinophilia and systemic symptoms (DRESS) | Cutaneous eruption, fever, eosinophilia, hepatic dysfunction, lymphadenopathy | Anticonvulsants, sulfonamides, minocycline, allopurinol |
References
- ↑ Khan, David A. (2010-02). "Drug allergy". The Journal of Allergy and Clinical Immunology. 125 (2 Suppl 2): –126-137. doi:10.1016/j.jaci.2009.10.028. ISSN 1097-6825. PMID 20176256. Unknown parameter
|coauthors=
ignored (help); Check date values in:|date=
(help) - ↑ Lee, Anne (2006). Adverse drug reactions. London Chicago: Pharmaceutical Press. ISBN 0853696012.